Back to Trades
Total Value
$91.2K
Net $91.2K sold
Filing Date
Jul 24, 2026
1 transaction
Sales
$91.2K
1 transaction
Trade Summary
On Jul 22, 2026, Dulac Edward J III, Insider, sold $91.2K of Intellia Therapeutics, Inc. (NTLA) across 1 transaction. The filing covers Common Stock and reflects net selling of $91.2K. Reported prices ranged from $11.25. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Intellia Therapeutics, Inc.
- Ticker Symbol
- NTLA
- CIK
- 0001652130
Insider Information
- Role
- Insider
- Location
- CAMBRIDGE, MA
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 22, 2026
- Accession Number
- 0001193125-26-316279
- Form Type
- 4
- Net Trading Amount
- -$91.2K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | Common Stock | 8,111 | $11.25 | Sale | $91.2K |
Want live alerts when Dulac Edward J III trades again?
Download Insider Trades to track NTLA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on July 22, 2026, and does not represent a volitional trade by the Reporting Person.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.28, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 22, 2026 at each separate price.